Micellar Curcumin and Metabolic Syndrome Biomarkers
Micellar Curcumin and Metabolic Syndrome Biomarkers
The purpose of this study is to investigate the effect of micellar curcumin on inflammation
 and lipid metabolism markers in subjects at risk for the metabolic syndrome.
Inclusion criteria:

 -  Total cholesterol > 5.2 mmol/L

 -  LDL cholesterol > 3.4 mmol/L

 -  Triglyceride > 2.26 mmol/L

 -  CRP > 2 mg/L

 Exclusion criteria:

 -  Intake of drugs or dietary supplements

 -  Pregnant women and breastfeeding mothers

 -  Smokers

 -  Previous illnesses such as heart attack, cancer or dementia

 -  Addiction